Press Releases

Date Title and Summary Additional Formats
Toggle Summary Medical Research Collaborating Center Selects Medidata to Meet Global Regulatory Requirements During Clinical Trials
One of the Leading Research Centers in South Korea Leverages the Medidata Clinical Cloud ® NEW YORK & SEOUL, South Korea --(BUSINESS WIRE)--Jan. 9, 2018-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that the
View HTML
Toggle Summary Medidata to Present at J.P. Morgan 36th Annual Healthcare Conference
NEW YORK --(BUSINESS WIRE)--Jan. 3, 2018-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that Rouven Bergmann , chief financial officer, will present at the J.P.
View HTML
Toggle Summary New Quartesian Agreement with Medidata Expands Sponsor Access to the Medidata Clinical Cloud® during Clinical Trials
Quartesian Signs Enterprise License Agreement to Offer Complete Access Across Markets to Medidata’s Industry Leading Cloud Platform NEW YORK & PRINCETON, N.J. --(BUSINESS WIRE)--Dec. 13, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based solutions and data analytics for
View HTML
Toggle Summary Medidata SCA Wins Scrip Award for Best Technological Development in Clinical Trials - Sponsor Focused
NEW YORK --(BUSINESS WIRE)--Dec. 6, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, is pleased to announce that the Medidata Synthetic Control Arm (SCA) was recognized at the 2017 Scrip Awards as the " Best Technological
View HTML
Toggle Summary Medidata Expands Partnership with CytomX Therapeutics to Centralize Management of Regulated and Nonregulated Content
New Agreement Includes Medidata RCM and eTMF Archive for End-to-End Inspection Readiness and Collaboration NEW YORK --(BUSINESS WIRE)--Dec. 5, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced that CytomX
View HTML
Toggle Summary Industry Survey Reveals Top 14 Technologies Necessary for a Unified eClinical Platform
Technologies fall within three main categories: Data Capture and Management, Trial Planning and Management, and Advanced Analytics NEW YORK --(BUSINESS WIRE)--Dec. 4, 2017-- Running a successful clinical trial or study is a complex and highly regulated process that requires vast operational
View HTML
Toggle Summary Medidata Presenting at the 2017 Partnerships in Clinical Trials Europe Conference
Event Brings Together Industry Leaders in Clinical Trials NEW YORK --(BUSINESS WIRE)--Nov. 28, 2017-- Medidata (NASDAQ:MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, announced that Anthony Costello , vice president of mobile health, and
View HTML
Toggle Summary Medidata to Present at Piper Jaffray Healthcare Conference
NEW YORK --(BUSINESS WIRE)--Nov. 21, 2017-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based technology and data analytics for clinical research, today announced the company’s participation in the 29 th Annual Piper Jaffray Healthcare Conference on Tuesday, November 28, 2017 in
View HTML
Toggle Summary Global Medical Devices Company, MEL MEDICAL Enterprises, Modernizes Clinical Research with Multi-Year Medidata eTMF Agreement
Company Accelerates Bladder Cancer Research by Unifying Content, Data, and Workflows NEW YORK & PETAH-TIKVA, Israel --(BUSINESS WIRE)--Nov. 20, 2017-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, today announced that MEL
View HTML
Toggle Summary Medidata Selected by ICON to Evolve Image Management and Accelerate Research Goals for Sponsors and Sites During Clinical Trials
Medidata Medical Imaging ® Provides End-to-End Control of Rapidly Growing Data Source NEW YORK & DUBLIN--(BUSINESS WIRE)--Nov. 15, 2017-- Medidata (NASDAQ: MDSO), the leading global provider of cloud-based solutions and data analytics for clinical research, and ICON (NASDAQ: ICLR), a global
View HTML

Investor Contact

Betsy Frank
Head of Investor Relations
+1 917 522 4620
bfrank@mdsol.com

Anthony D'Amico
Senior Director, Investor Relations
+1 732 767 4331
adamico@mdsol.com